Literature DB >> 9622089

Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer.

M Kimura1, T Furukawa, T Abe, T Yatsuoka, E M Youssef, T Yokoyama, H Ouyang, Y Ohnishi, M Sunamura, M Kobari, S Matsuno, A Horii.   

Abstract

Using the method of microsatellite analysis, we studied 40 tissues with pancreatic ductal adenocarcinoma and identified two commonly deleted regions on the long arm of chromosome 12. One (region A) was found between D12S81 and D12S1719 at 12q21 at a frequency of 67.5%, and the other (region B) was located between D12S360 and D12S78 at 12q22-q23.1 at a frequency of 60%; the latter was reported previously (M. Kimura, et al. Genes Chromosomes Cancer, 17: 88-93, 1996). The results of microsatellite analyses were verified by fluorescence in situ hybridization. We further analyzed 19 pancreatic cancer cell lines by fluorescence in situ hybridization and found that 10 of them showed allelic loss at D12S81 and 6 showed allelic loss at D12S360. Yeast artificial chromosome contigs were constructed to cover the deleted regions. Region B was completely covered by a 650-kb yeast artificial chromosome clone. The frequently deleted regions in chromosome 12q in pancreatic cancer that were identified here may provide new avenues for isolating novel tumor suppressor genes.

Entities:  

Mesh:

Year:  1998        PMID: 9622089

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes.

Authors:  Luisa Di Stefano; Michael Rugaard Jensen; Kristian Helin
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

Review 2.  PAR-4 as a possible new target for pancreatic cancer therapy.

Authors:  Asfar S Azmi; Philip A Philip; Syed F Zafar; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Expert Opin Ther Targets       Date:  2010-06       Impact factor: 6.902

Review 3.  Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

Authors:  T Shrestha-Bhattarai; V M Rangnekar
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

4.  The atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence.

Authors:  Ozlem Aksoy; Agustin Chicas; Tianying Zeng; Zhen Zhao; Mila McCurrach; Xiaowo Wang; Scott W Lowe
Journal:  Genes Dev       Date:  2012-07-15       Impact factor: 11.361

5.  Genomic analysis of the thymine-DNA glycosylase (TDG) gene on 12q22-q24.1 in human pancreatic ductal adenocarcinoma.

Authors:  T Yatsuoka; T Furukawa; T Abe; T Yokoyama; M Sunamura; M Kobari; S Matsuno; A Horii
Journal:  Int J Pancreatol       Date:  1999-04

Review 6.  Gene therapy for pancreatic cancer targeting the genomic alterations of tumor suppressor genes using replication-selective oncolytic adenovirus.

Authors:  Makoto Sunamura; Masaru Oonuma; Fuyuhiko Motoi; Hisashi Abe; Yukoh Saitoh; Toru Hoshida; Shigeru Ottomo; Akira Horii; Seiki Matsuno
Journal:  Hum Cell       Date:  2002-09       Impact factor: 4.174

7.  Abrogation of DUSP6 by hypermethylation in human pancreatic cancer.

Authors:  Shanhai Xu; Toru Furukawa; Naomi Kanai; Makoto Sunamura; Akira Horii
Journal:  J Hum Genet       Date:  2005-04-12       Impact factor: 3.172

8.  Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer.

Authors:  B G Schneider; S Y Rha; H C Chung; J C Bravo; R Mera; J C Torres; K T Plaisance; R Schlegel; C M McBride; X T Reveles; R J Leach
Journal:  Mol Pathol       Date:  2003-06

9.  Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells.

Authors:  Nadia El-Guendy; Yanming Zhao; Sushma Gurumurthy; Ravshan Burikhanov; Vivek M Rangnekar
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

10.  Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer.

Authors:  Toru Furukawa; Makoto Sunamura; Fuyuhiko Motoi; Seiki Matsuno; Akira Horii
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.